Emerging Variants of Castration-Resistant Prostate Cancer.

Emerging Variants of Castration-Resistant Prostate Cancer.

Item
http://www.wikidata.org/entity/Q39210257
Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation.Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer.Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer.Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models.Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network.“Splice” a way towards neuroendocrine prostate cancer
P2860

Emerging Variants of Castration-Resistant Prostate Cancer.

Item
http://www.wikidata.org/entity/Q39210257
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Emerging Variants of Castration-Resistant Prostate Cancer.
@en
Emerging Variants of Castration-Resistant Prostate Cancer.
@nl
type
label
Emerging Variants of Castration-Resistant Prostate Cancer.
@en
Emerging Variants of Castration-Resistant Prostate Cancer.
@nl
prefLabel
Emerging Variants of Castration-Resistant Prostate Cancer.
@en
Emerging Variants of Castration-Resistant Prostate Cancer.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Emerging Variants of Castration-Resistant Prostate Cancer.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P932